ask="N/A"
ask_size="N/A"
average_daily_volume="246155"
bid="1.21"
bid_size="3000"
book_value="0.68"
change="+0.07"
change_from_200_day_moving_average="0.20"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-0.23"
change_From_52_week_low="0.48"
change_in_percent="+5.78%"
close="1.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.27"
ebitda="-15.76M"
eps_estimate_current_year="-0.28"
eps_estimate_next_quarter="-0.05"
eps_estimate_next_year="-0.18"
ex_dividend_date="N/A"
float_shares="44504000"
high="1.24"
high_52_weeks="1.42"
last_trade_date="2/15/2017"
last_trade_price="1.19"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.12"
low_52_weeks="0.71"
market_capitalization="67.15M"
moving_average_200_day="0.99"
moving_average_50_day="0.98"
name="BioLineRx Ltd."
notes="N/A"
one_year_target_price="2.33"
open="1.14"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+20.03%"
percent_change_from_50_day_moving_average="+21.54%"
percent_change_from_52_week_high="-16.20%"
percent_change_from_52_week_low="+67.61%"
previous_close="1.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.64"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="56432000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="BLRX"
volume="831230"
weeks_range_52="0.71 - 1.42"
